UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Immunological differences between primary and metastatic breast cancer

Annals of oncology, 2018-11, Vol.29 (11), p.2232-2239

2018

Volltextzugriff (PDF)

Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma

Scientific reports, 2022-06, Vol.12 (1), p.10976-10976, Article 10976

2022

Volltextzugriff (PDF)

Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ER[alpha] Coactivator Interactions

Chirality (New York, N.Y.), 2013-10, Vol.25 (10), p.628-642

2013

Volltextzugriff (PDF)

Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ERα Coactivator Interactions

Chirality (New York, N.Y.), 2013-10, Vol.25 (10), p.628-642

2013

Volltextzugriff (PDF)

Abstract P2-09-06: Quantitative spatial profiling of tumor associated macrophages and the PD-1/PD-L1 interaction in breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-09-06

2018

Volltextzugriff (PDF)

532 TRANSCRIPTOME ANALYSIS OF QUERCETIN EFFECT IN HEPATOCELLULAR CANCER CELLS

Journal of hepatology, 2009, Vol.50, p.S197-S198

2009

Volltextzugriff (PDF)

Abstract P4-03-04: Tumor infiltrating macrophages, lymphocytes and matrix metalloproteinase 9 (MMP-9) expression in breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-03-04

2017

Volltextzugriff (PDF)

Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis

The International journal of developmental biology, 2011, Vol.55 (7-9), p.869

2011

Volltextzugriff (PDF)

333TiP AMEERA-1: Phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with alpelisib in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2–) PIK3CA-mutated advanced breast cancer

Annals of oncology, 2021-09, Vol.32, p.S511-S512

2021

Volltextzugriff (PDF)

1648P Deep learning identifies oncogenic genetic alterations in BRAF and NTRK in H&E whole slide images from thyroid carcinomas

Annals of oncology, 2022-09, Vol.33, p.S1296

2022

Volltextzugriff (PDF)

264P AMEERA-1: Subgroup analyses of phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with palbociclib in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (aBC)

Annals of oncology, 2021-09, Vol.32, p.S476-S477

2021

Volltextzugriff (PDF)

Membrane-initiated steroid action in breast and prostate cancer

Steroids, 2008-10, Vol.73 (9), p.953-960

2008

Volltextzugriff (PDF)

277MO SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study

Annals of oncology, 2020-09, Vol.31, p.S351-S351

2020

Volltextzugriff (PDF)

P8 Potentiation of erythropoietin (EPO) action by membrane steroid receptor agonists

Breast (Edinburgh), 2007, Vol.16, p.S14-S15

2007

Volltextzugriff (PDF)

Abstract PD6-02: Immunological differences between primary and metastatic breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD6-02-PD6-02

2018

Volltextzugriff (PDF)

Erythropoietin and steroid membrane initiated actions interact in breast cancer cells leading to enhanced cell survival

European journal of cancer supplements, 2008, Vol.6 (9), p.78-78

2008

Volltextzugriff (PDF)

Abstract P4-02-01: Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-02-01

2019

Volltextzugriff (PDF)

P40 Erythropoietin (EPO) and its receptors (EPOR) detection in human breast cancer specimens: correlation with steroid receptors (membrane intracellular) and other biological and clinical indices

Breast (Edinburgh), 2007, Vol.16, p.S23-S24

2007

Volltextzugriff (PDF)

Regulation of TNF-superfamily members by erythropoietin, in breast cancer

European journal of cancer supplements, 2008, Vol.6 (9), p.126-127

2008

Volltextzugriff (PDF)

Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study

CANCER RESEARCH, 2019, Vol.79 (4)

2019

Volltextzugriff (PDF)

FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function

Transplantation proceedings, 1991-12, Vol.23 (6), p.3200-3201

1991

Volltextzugriff (PDF)

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa

British journal of dermatology (1951), 2008-03, Vol.158 (3), p.567-572

2008

Volltextzugriff (PDF)

Serum of patients with septic shock stimulates the expression of Trem-1 on U937 monocytes

Inflammation research, 2009-03, Vol.58 (3), p.127-132

2009

Volltextzugriff (PDF)

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa: Etanercept in hidradenitis suppurativa

British journal of dermatology (1951), 2008-03, Vol.158 (3), p.567-572

2008

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Tagungsberichte
(1)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Humans
(8)
Life Sciences & Biomedicine
(8)
Female
(6)
Adult
(4)
Hematology, Oncology And Palliative Medicine
(4)
Male
(4)
Middle Aged
(4)
Aged
(3)
Animals
(3)
Adolescent
(2)
Aged, 80 And Over
(2)
Biological And Medical Sciences
(2)
Breast Cancer
(2)
Breast Neoplasms - Pathology
(2)
Cell Biology
(2)
Cytokines
(2)
Dermatology
(2)
Estrogen
(2)
Immunology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(5)
Cancer Research
(4)
Breast
(2)
British Journal Of Dermatology
(2)
Chirality
(2)
European Journal Of Cancer Supplements
(2)
Inflammation Research
(1)
Journal Of Hepatology
(1)
Oncotarget
(1)
Scientific Reports
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunological differences between primary and metastatic breast cancer

Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma

Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ER[alpha] Coactivator Interactions

Identification of Polyproline II Regions Derived From the Proline-Rich Nuclear Receptor Coactivators PNRC and PNRC2: New Insights for ERα Coactivator Interactions

Abstract P2-09-06: Quantitative spatial profiling of tumor associated macrophages and the PD-1/PD-L1 interaction in breast cancer

532 TRANSCRIPTOME ANALYSIS OF QUERCETIN EFFECT IN HEPATOCELLULAR CANCER CELLS

Abstract P4-03-04: Tumor infiltrating macrophages, lymphocytes and matrix metalloproteinase 9 (MMP-9) expression in breast cancer

Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis

333TiP AMEERA-1: Phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with alpelisib in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2–) PIK3CA-mutated advanced breast cancer

1648P Deep learning identifies oncogenic genetic alterations in BRAF and NTRK in H&E whole slide images from thyroid carcinomas

264P AMEERA-1: Subgroup analyses of phase I/II study of amcenestrant (SAR439859), an oral selective estrogen receptor (ER) degrader (SERD), with palbociclib in postmenopausal women with ER+/ human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (aBC)

Membrane-initiated steroid action in breast and prostate cancer

277MO SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study

P8 Potentiation of erythropoietin (EPO) action by membrane steroid receptor agonists

Abstract PD6-02: Immunological differences between primary and metastatic breast cancer

Erythropoietin and steroid membrane initiated actions interact in breast cancer cells leading to enhanced cell survival

Abstract P4-02-01: Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study

P40 Erythropoietin (EPO) and its receptors (EPOR) detection in human breast cancer specimens: correlation with steroid receptors (membrane intracellular) and other biological and clinical indices

Regulation of TNF-superfamily members by erythropoietin, in breast cancer

Analytical validation of an automated digital scoring protocol for Ki67: International multicenter collaboration study

FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa

Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions

Serum of patients with septic shock stimulates the expression of Trem-1 on U937 monocytes

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa: Etanercept in hidradenitis suppurativa

Suchergebnisse filtern